Home›Stock Screener›Piramal Pharma›Shareholding Pattern

Piramal Pharma Shareholding Pattern

Piramal Pharma shareholding pattern. As of Sept 2026, Piramal Pharma (PPLPHARMA) promoter holding 34.80%, FII 13.65%, DII 14.44%, public 13.27%, total shareholders 413,197. Compare with PPLPHARMA fair value to assess whether the stock is under or overvalued.

Promoter Holding 34.80%
FII Holding 13.65%
DII Holding 14.44%
Public Holding 13.27%
Total Shareholders 413,197
As of Sept 2026

PPLPHARMA Recent Shareholding Changes — Promoter, FII & DII

Piramal Pharma promoter, FII and DII holding change from Jun 2026 to Sept 2026, FII +1.13%, DII -0.13%. For live price, key ratios and the full company profile, see Piramal Pharma stock price NSE.

Promoter Holding Change
Jun 2026 to Sept 2026
No Change
FII Holding Change
Jun 2026 to Sept 2026
+1.13%
DII Holding Change
Jun 2026 to Sept 2026
-0.13%
Public Holding Change
Jun 2026 to Sept 2026
-1.27%

Piramal Pharma Quarterly Shareholding Trend — Promoter, FII, DII & Public

PPLPHARMA promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Explore PPLPHARMA intrinsic value to estimate fundamental worth using multiple valuation models.

Promoter
FII
DII
Public
Government

PPLPHARMA Shareholding Pattern Data — Quarterly History

Piramal Pharma quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2026 34.80% 13.65% 14.44% 0.00% 13.27% 23.84% 100.00% 413,197
Jun 2026 34.80% 12.52% 14.57% 0.00% 14.54% 23.57% 100.00% 461,096
Mar 2026 34.86% 30.18% 15.61% 0.00% 13.74% 5.61% 100.00% 450,661
Dec 2025 34.86% 29.66% 15.69% 0.00% 14.11% 5.69% 100.01% 453,830
Sept 2025 34.86% 30.27% 14.89% 0.00% 14.12% 5.86% 100.00% 462,511
Jun 2025 34.86% 30.86% 14.26% 0.00% 14.07% 5.95% 100.00% 458,430
Mar 2025 34.95% 31.49% 14.78% 0.00% 13.11% 5.66% 99.99% 432,843
Dec 2024 34.95% 31.68% 14.10% 0.00% 13.29% 5.98% 100.00% 418,442
Sept 2024 34.95% 31.73% 13.81% 0.00% 13.29% 6.22% 100.00% 359,751
Jun 2024 34.95% 31.42% 12.95% 0.00% 13.94% 6.74% 100.00% 306,398
Mar 2024 35.02% 30.59% 12.12% 0.00% 15.13% 7.14% 100.00% 297,996
Dec 2023 35.02% 32.51% 9.68% 0.00% 15.57% 7.22% 100.00% 292,312
Sept 2023 35.02% 32.37% 8.02% 0.00% 16.95% 7.64% 100.00% 297,225
Aug 2023 35.02% 18.04% 7.83% 0.00% 16.81% 22.30% 100.00% 295,773
Jun 2023 34.79% 20.00% 5.49% 0.00% 16.77% 22.95% 100.00% 277,270
Mar 2023 34.79% 20.00% 4.99% 0.00% 13.94% 26.29% 100.01% 241,359
Dec 2022 34.79% 20.00% 5.28% 0.00% 11.80% 28.14% 100.01% 229,960
Oct 2022 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 100.00% 179,948
Sept 2022 34.79% 20.00% 4.86% 0.00% 7.42% 32.92% 99.99% 179,957
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2026 34.80% 13.65% 14.44% 0.00% 13.27% 23.84% 100.00% 413,197
Jun 2026 34.80% 12.52% 14.57% 0.00% 14.54% 23.57% 100.00% 461,096
Mar 2026 34.86% 30.18% 15.61% 0.00% 13.74% 5.61% 100.00% 450,661
Dec 2025 34.86% 29.66% 15.69% 0.00% 14.11% 5.69% 100.01% 453,830
Sept 2025 34.86% 30.27% 14.89% 0.00% 14.12% 5.86% 100.00% 462,511
Jun 2025 34.86% 30.86% 14.26% 0.00% 14.07% 5.95% 100.00% 458,430
Mar 2025 34.95% 31.49% 14.78% 0.00% 13.11% 5.66% 99.99% 432,843
Dec 2024 34.95% 31.68% 14.10% 0.00% 13.29% 5.98% 100.00% 418,442
Sept 2024 34.95% 31.73% 13.81% 0.00% 13.29% 6.22% 100.00% 359,751
Jun 2024 34.95% 31.42% 12.95% 0.00% 13.94% 6.74% 100.00% 306,398
Mar 2024 35.02% 30.59% 12.12% 0.00% 15.13% 7.14% 100.00% 297,996
Dec 2023 35.02% 32.51% 9.68% 0.00% 15.57% 7.22% 100.00% 292,312
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 34.86% 30.18% 15.61% 0.00% 13.74% 5.61% 100.00% 450,661
Dec 2025 34.86% 29.66% 15.69% 0.00% 14.11% 5.69% 100.01% 453,830
Dec 2024 34.95% 31.68% 14.10% 0.00% 13.29% 5.98% 100.00% 418,442
Dec 2023 35.02% 32.51% 9.68% 0.00% 15.57% 7.22% 100.00% 292,312
Dec 2022 34.79% 20.00% 5.28% 0.00% 11.80% 28.14% 100.01% 229,960